V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014217 | 160006962 | 1.55 | 64.5 | Palliative (P) | 2017-04-10 | 2017-07-24 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | GEMCITABINE | 101109654 |
| 160014218 | 160006963 | 1.8 | 62.1 | Palliative (P) | 2019-08-08 | 2019-08-14 | ETOP 13-18 BEAT-meso Trial | 02 | N | VINORELBINE | 100231245 |
| 160014220 | 160006964 | 1.75 | null | Palliative (P) | 2019-11-30 | 2019-12-15 | Trial Unspecified | N | N | TRIAL UNSPECIFIED | 100928815 |
| 160014221 | 160006965 | 1.77 | 88.6 | Neo-adjuvant (N) | 2018-01-25 | 2018-02-11 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101604793 |
| 160014224 | 160006966 | 1.83 | 68.4 | Palliative (P) | 2018-03-30 | 2018-03-30 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101212554 |
| 160014225 | 160006967 | 0 | 0 | Palliative (P) | 2019-08-11 | 2019-08-12 | Doxorubicin + Olaratumab | 02 | null | ATOMIC-MESO TRIAL | 101291401 |
| 160014226 | 160006968 | 1.67 | null | Curative (C) | 2019-12-10 | 2019-12-10 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101533771 |
| 160014227 | 160006969 | 1.7 | 73.6 | 03 | 2019-06-10 | 2019-06-13 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101656471 |
| 160014229 | 160006970 | null | 71 | Palliative (P) | 2017-05-23 | 2017-05-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100329596 |
| 160014230 | 160006971 | 1.63 | 65.5 | Neo-adjuvant (N) | 2018-02-05 | 2018-02-07 | Docetaxel + Gemcitabine with GCSF | 02 | N | DOXORUBICIN | 100654567 |
| 160014231 | 160006972 | 1.7 | 74.6 | null | 2017-12-01 | 2017-12-09 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 101452073 |
| 160014232 | 160006973 | 1.7 | 72.3 | Palliative (P) | 2019-08-22 | 2019-08-30 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101221741 |
| 160014235 | 160006974 | 1.63 | 65.25 | Palliative (P) | 2016-12-31 | 2016-12-31 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100968526 |
| 160014236 | 160006975 | 1.66 | 46 | Palliative (P) | 2016-06-29 | 2016-06-29 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100196389 |
| 160014238 | 160006976 | 1.43 | 77 | Neo-adjuvant (N) | 2016-08-07 | 2016-08-07 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | DOXORUBICIN + IFOSFAMIDE | 101546371 |
| 160014239 | 160006977 | 1.7 | 84.35 | Palliative (P) | 2018-04-28 | 2018-05-05 | CARBOPLATIN + PACLITAXEL | 02 | N | EW EUROEWING 2012 ARM A VIDE | 100669593 |
| 160014240 | 160006978 | 1.55 | 87.1 | Palliative (P) | 2016-06-16 | 2016-07-09 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101075444 |
| 160014241 | 160006979 | 1.66 | 80 | Palliative (P) | 2016-11-30 | 2016-12-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101557974 |
| 160014243 | 160006980 | 1.82 | 57 | Curative (C) | 2017-05-08 | 2017-05-11 | Pemetrexed | null | N | PEMETREXED | 100035126 |
| 160014245 | 160006981 | 1.61 | 71.8 | Palliative (P) | 2018-06-20 | 2018-06-28 | ECX | N | N | DOXORUBICIN + OLARATUMAB | 101632385 |
| 160014246 | 160006982 | 1.59 | 70 | Palliative (P) | 2016-11-11 | 2016-11-11 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101528673 |
| 160014249 | 160006983 | 1.59 | 71.9 | Palliative (P) | 2019-09-30 | 2019-10-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100034993 |
| 160014250 | 160006984 | 1.78 | 62 | null | 2018-07-05 | 2018-07-25 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101556141 |
| 160014251 | 160006985 | 1.7 | 69.5 | Palliative (P) | 2018-07-26 | 2018-08-10 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | CISPLATIN + DOXORUBICIN | 100231425 |
| 160014252 | 160006986 | 1.77 | 63.4 | Palliative (P) | 2019-08-12 | 2019-08-16 | Doxorubicin 75mg/m2 | 2 | N | DOXORUBICIN | 101626147 |
| 160014253 | 160006987 | 1.62 | 67.4 | Palliative (P) | 2016-02-22 | 2016-02-22 | EW EuroEwing 2012 Arm B VDC | 02 | N | ECX | 100045106 |
| 160014255 | 160006988 | 1.62 | 71 | null | 2019-12-03 | 2019-12-17 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100927878 |
| 160014256 | 160006989 | 1.72 | 110 | Palliative (P) | 2016-12-25 | 2016-12-30 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101268129 |
| 160014257 | 160006990 | 1.7 | 53 | Palliative (P) | 2016-06-15 | 2016-06-27 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100968852 |
| 160014258 | 160006991 | 1.77 | 76.4 | null | 2017-12-18 | 2017-12-25 | IPILIMUMAB + NIVOLUMAB | 02 | Y | TRABECTEDIN | 100245727 |
| 160014259 | 160006992 | 1.71 | 10.9 | Curative (C) | 2016-05-23 | 2016-05-23 | Ifosfamide | N | N | TRIAL UNSPECIFIED | 100220624 |
| 160014260 | 160006993 | null | null | Adjuvant (A) | 2019-10-19 | 2019-11-07 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101338387 |
| 160014263 | 160006994 | 0 | 0 | Adjuvant (A) | 2019-03-16 | 2019-04-02 | GEMCARBO | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101252181 |
| 160014264 | 160006995 | 1.81 | 86.2 | Palliative (P) | 2019-02-11 | 2019-02-11 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100627361 |
| 160014265 | 160006996 | 0 | 0 | Curative (C) | 2017-07-23 | 2017-07-23 | EW EuroEwing 2012 Arm B VDC | 02 | N | OCTREOTIDE | 101288697 |
| 160014266 | 160006997 | 0 | 43.4 | Palliative (P) | 2017-08-24 | 2017-08-28 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | ENZALUTAMIDE | 101594067 |
| 160014267 | 160006998 | 1.75 | 52.15 | Disease modification (D) | 2019-01-05 | 2019-02-27 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101022381 |
| 160014268 | 160006999 | 1.67 | 69.7 | Neo-adjuvant (N) | 2018-08-16 | 2018-08-30 | Cisplatin + Pemetrexed | 01 | Y | CISPLATIN + PEMETREXED | 101718031 |
| 160014271 | 160007000 | null | null | Palliative (P) | 2017-07-23 | 2017-08-02 | GemCarbo Days 1+8 | 01 | null | LIPOSOMAL DOXORUBICIN | 100692512 |
| 160014272 | 160007001 | 1.74 | 75.7 | Curative (C) | 2016-08-23 | 2016-08-24 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100808748 |
| 160014273 | 160007002 | 1.48 | 68.2 | Adjuvant (A) | 2016-05-31 | 2016-06-04 | Doxorubicin + Olaratumab | 02 | N | ICON8B TRIAL | 100163611 |
| 160014274 | 160007003 | 1.7 | 56.6 | Neo-adjuvant (N) | 2018-01-21 | 2018-01-24 | Cisplatin + Pemetrexed | 2 | N | CISPLATIN + PEMETREXED | 101194090 |
| 160014278 | 160007004 | null | null | Curative (C) | 2020-01-13 | 2020-01-13 | Cisplatin + Pemetrexed | N | N | TRIAL | 101533394 |
| 160014279 | 160007005 | 1.78 | 98.6 | 03 | 2018-05-02 | 2018-05-03 | EW EuroEwing 2012 Arm A VIDE | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 101321278 |
| 160014280 | 160007006 | 1.87 | 82.2 | 03 | 2018-12-14 | 2019-01-04 | Carboplatin + Paclitaxel (3 weekly) | N | N | VIDE | 100839373 |
| 160014281 | 160007007 | 1.89 | null | null | 2019-08-09 | 2019-08-21 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100240352 |
| 160014282 | 160007008 | 1.68 | 65.5 | null | null | 2016-02-05 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100985017 |
| 160014283 | 160007009 | 1.74 | 85.7 | null | 2018-06-25 | 2018-07-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101271848 |
| 160014284 | 160007010 | 1.86 | 94 | Palliative (P) | 2020-01-09 | 2020-01-19 | Doxorubicin + Ifosfamide | N | N | PACLITAXEL | 100906160 |
| 160014285 | 160007011 | 1.8 | 58.5 | Curative (C) | 2018-08-07 | 2018-08-21 | Imatinib 400mg | 02 | N | LIPOSOMAL DOXORUBICIN | 101493199 |